Across TCGA pan-cancer cohorts, ANKRD34C RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated ANKRD34C data layer compared with 4 for mutation status.
The strongest signal is observed in kidney chromophobe (KICH), where higher ANKRD34C RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ANKRD34C expression acts as an unfavorable survival marker, although some lineages such as ESCA and SARC show a favorable association.
KICH, ESCA, and KIRP are the cancer types where ANKRD34C RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.